News

The survey of households found that although 80% of residents had heard of Rocky Mountain spotted fever, less than half used pesticides to prevent the presence of ticks.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 14, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Although conducting whole genomic sequencing creates an upfront cost in screening patients for MRSA, a new study finds that it’s a cost-effective way to prevent new infections and related deaths.

The use of high-dose daptomycin in combination with a β-lactam antibiotic to treat enterococcal bacteremia is supported by pharmacodynamics.

A 10-minute cycle of PX-UV light on glass slides inoculated with C auris reduced the number of colony forming units per milliliter by 99.6%.

Kaye speaks on the recently approved drug for the treatment of adults with cUTI or cIAI with limited or no alternative treatment options.

One of the biggest studies to-date on the relationship between cefepime plasma concentrations and neurotoxicity has identified which patients are at greatest risk.

From anthrax to Zika, there's a lot of diversity in the spectrum of biological threats we face daily.

Dr. Tedros has accepted the World Health Organization (WHO) International Health Regulations Emergency Committee's recommendation.

Health officials have linked ground bison meat to a multistate outbreak of E coli O103 and E coli O121 infections.

Several states have or are considering laws that would circumvent consent from anti-vax parents.

The guidelines include a new section featuring recommendations for treating transgender people living with HIV.

RECARBRIO (imipenem, cilastatin, and relebactam) has been approved for the treatment of complicated urinary tract infections and complicated intra-abdominal bacterial infections where there are limited or no alternative treatments available.

Mosaico plans to register 3800 HIV-negative participants aged 18 to 60 years when enrollment opens later this year.

The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.

The regulations require that hospitals in New York follow protocols for sepsis that include early detection and treatment, staff training, and reporting of adherence and clinical outcomes to the state.

Long-acting reservoir-style PrEP implants could help solve adherence issues.

PrEP awareness among these MSM rose from 60% to 90% from 2014 to 2017, and PrEP use increased from 6% to 35%.

New research assesses potential alternatives to a daily dose of emtricitabine/tenofovir. It finds mixed results.

Infections associated with injection drug misuse are on the rise—here's why we need to pay attention.

This In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 7, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Of the 216 infants studied, 31.5% had delayed neurodevelopment and/or eye abnormalities and/or hearing deficits when evaluated as late as 32 months of age.

A 2-dose course of the vaccine reduced the incidence of herpes zoster significantly over a median-follow up of 21 months when compared with placebo.